Northwestern Mutual Wealth Management’s Arcturus Therapeutics ARCT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-58	Closed	-$1.35K	–	3611
2024 Q3	$1.35K	Buy	+58	New	+$1.24K	﹤0.01%	3193
2023 Q3	–	Sell	-50	Closed	-$1.43K	–	3279
2023 Q2	$1.43K	Buy	+50	New	+$1.36K	﹤0.01%	3041
2022 Q1	–	Sell	-4,265	Closed	-$158K	–	3089
2021 Q4	$158K	Buy	+4,265	New	+$174K	﹤0.01%	1522
2021 Q2	–	Sell	-86	Closed	-$4K	–	2984
2021 Q1	$4K	Buy	+86	New	+$5.13K	﹤0.01%	2476

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northwestern Mutual Wealth Management's ARCT Position: Q4 2024 in Review

Northwestern Mutual Wealth Management sold out of Arcturus Therapeutics (ARCT) in Q4 2024, closing a stake of 58 shares — an estimated $1.35K sold.

Northwestern Mutual Wealth Management first reported a position in ARCT in Q1 2021 and held it in 4 quarters. The position peaked at $158K in Q4 2021. 147 funds tracked by Wall St. Rank hold ARCT as of Q4 2024.

Northwestern Mutual Wealth Management reported no remaining Arcturus Therapeutics position as of Q4 2024 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 58 Arcturus Therapeutics shares in Q4 2024, an estimated $1.35K.
Northwestern Mutual Wealth Management first reported a position in Arcturus Therapeutics in Q1 2021 and held it in 4 quarters.
Northwestern Mutual Wealth Management's Arcturus Therapeutics position peaked at $158K in Q4 2021.
147 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.